Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

CDXS

Codexis (CDXS)

Codexis Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CDXS
日付受信時刻ニュースソース見出しコード企業名
2025/02/0109 : 08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
2025/01/1708 : 28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
2025/01/1707 : 04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
2025/01/1706 : 05GlobeNewswire Inc.Codexis Appoints Christos Richards to Board of DirectorsNASDAQ:CDXSCodexis Inc
2025/01/1106 : 05GlobeNewswire Inc.Codexis Announces New Employment Inducement GrantsNASDAQ:CDXSCodexis Inc
2025/01/0306 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
2024/12/0706 : 05GlobeNewswire Inc.Codexis Announces New Employment Inducement GrantsNASDAQ:CDXSCodexis Inc
2024/11/2006 : 05GlobeNewswire Inc.Codexis to Participate in Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:CDXSCodexis Inc
2024/11/1506 : 53Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CDXSCodexis Inc
2024/11/1506 : 05GlobeNewswire Inc.Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi TherapeuticsNASDAQ:CDXSCodexis Inc
2024/11/1306 : 25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
2024/11/1306 : 05GlobeNewswire Inc.Codexis Announces Appointment of Raymond De Vré, PhD, to Board of DirectorsNASDAQ:CDXSCodexis Inc
2024/11/1306 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
2024/11/1206 : 05GlobeNewswire Inc.Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi TherapeuticsNASDAQ:CDXSCodexis Inc
2024/11/0906 : 05GlobeNewswire Inc.Codexis Announces New Employment Inducement GrantsNASDAQ:CDXSCodexis Inc
2024/11/0506 : 05GlobeNewswire Inc.Codexis to Participate in Upcoming Healthcare ConferencesNASDAQ:CDXSCodexis Inc
2024/11/0105 : 18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CDXSCodexis Inc
2024/11/0105 : 16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
2024/11/0105 : 05GlobeNewswire Inc.Codexis Reports Third Quarter 2024 Financial ResultsNASDAQ:CDXSCodexis Inc
2024/10/2905 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
2024/10/2505 : 05GlobeNewswire Inc.Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual MeetingNASDAQ:CDXSCodexis Inc
2024/10/2305 : 05GlobeNewswire Inc.Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of DirectorsNASDAQ:CDXSCodexis Inc
2024/10/2305 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
2024/10/1420 : 05GlobeNewswire Inc.Codexis Announces New Employment Inducement GrantsNASDAQ:CDXSCodexis Inc
2024/10/1107 : 20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
2024/10/1107 : 20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
2024/10/1107 : 19Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
2024/10/1105 : 05GlobeNewswire Inc.Codexis to Report Third Quarter 2024 Financial Results on October 31NASDAQ:CDXSCodexis Inc
2024/10/0305 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
2024/10/0305 : 05GlobeNewswire Inc.Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of CompanyNASDAQ:CDXSCodexis Inc
 Showing the most relevant articles for your search:NASDAQ:CDXS